| ACCESS | Ambulatory Care Clinic Effectiveness Systems Study; automated cervical cell screening system |
|---|---|
| AMS | ablepharon-microstomia syndrome; acute mountain sickness; adenosylmethionine synthetase; aggravated ... |
| BCSI | breast cancer screening indicator |
| B-MAST | short Michigan Alcoholism Screening Test |
| BST | bacteriuria screening test; blood serologic test; brief stimulus therapy |
| differential screening | Process in development of a multicellular organism by which cells become specialised for particular functions. Requires that there is selective expression of portions of the genome, the fully differentiated state may be preceded by a stage in which the cell is already programmed for differentiation but is not yet expressing the characteristic phenotype determination. (18 Nov 1997) |
|---|---|
| drug screening | Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. (12 Dec 1998) |
| drug screening assays, antitumour | Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumour growth parameters in laboratory animals. (12 Dec 1998) |
| familial screening | Screening directed at close relatives of probands with diseases that may lie latent, as in age-dependent dominant traits, or that may involve risk to progeny, as X-linked traits. (05 Mar 2000) |